Sava Infond D.O.O. Novo Nordisk A S Transaction History
Sava Infond D.O.O.
- $524 Billion
- Q1 2025
A detailed history of Sava Infond D.O.O. transactions in Novo Nordisk A S stock. As of the latest transaction made, Sava Infond D.O.O. holds 20,700 shares of NVO stock, worth $1.59 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
20,700
Previous 18,500
11.89%
Holding current value
$1.59 Million
Previous $1.59 Billion
9.67%
% of portfolio
0.27%
Previous 0.28%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,769Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.45 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.14 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$954 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$949 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$914 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $174B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...